[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341712-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341712-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","understanding-the-function-of-pax5-in-development-of-docetaxel-resistant-neuroendocrine-like-prostate-cancers","Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers","","Resistance to androgen receptor signaling inhibitor therapies drives therapy-induced neuroendocrine-like prostate cancer (t-NEPC), a highly aggressive subtype with poor survival and taxane-refractory behavior. Adenocarcinomas lose luminal features and acquire neuro-basal traits, yet the mechanism linking neuronal adaptation to taxane resistance remains unclear. Using ATAC-seq, acetylated-histone ChIP-seq, and RNA-seq in NE-like models, the study identifies Pax5 as a key transcription factor promoting neuroendocrine-associated gene expression. Pax5 depletion disrupts neurite-mediated communication and reduces growth factor receptor activation, sensitizing cells to docetaxel. t-NEPC-specific hydroxymethylation at Pax5 promoter CpG islands supports Pbx1 binding and Pax5 activation, suggesting targeting the Pax5 axis could restore taxane sensitivity. ",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/understanding-the-function-of-pax5-in-development-of-docetaxel-resistant-neuroendocrine-like-prostate-cancers/341712/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/understanding-the-function-of-pax5-in-development-of-docetaxel-resistant-neuroendocrine-like-prostate-cancers/341712.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in t-NEPC?","Question",{"text":63,"@type":64},"The study addresses why therapy-induced neuroendocrine-like prostate cancer becomes resistant to taxane-based therapies despite prior androgen receptor signaling inhibitor treatment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers identify transcription factors involved in neuroendocrine-like gene programs?",{"text":68,"@type":64},"They performed ATAC-seq, acetylated-histone ChIP-seq, and RNA-seq in NE-like cell line models, then analyzed promoters of transcriptionally active and significantly enriched neuroendocrine-like cancer-specific genes.",{"name":70,"@type":61,"acceptedAnswer":71},"What is Pax5’s proposed role in docetaxel resistance and tumor-cell communication?",{"text":72,"@type":64},"Pax5 is proposed as an important transcription factor for neuronal gene expression in t-NEPC, and its depletion disrupts neurite-mediated cellular communication while reducing growth factor receptor activation, thereby sensitizing cells to docetaxel.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341712,1790386573,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nUnderstanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers  \nSreyashi Bhattacharya1,8, Hannah L. Harris2,8, Ridwan Islam 1, Sanika Bodas2, Navatha Polavaram 1, Juhi Mishra3, Dipanwita Das 1, Parthasarathy Seshacharyulu 1, Achyuth Kalluchi2, Anirban Pal4, Manish Kohli5, Subodh M. Lele1, Michael Muders6, Surinder K. Batra 1, Paramita M. Ghosh 7, Kaustubh Datta1,3, M. Jordan Rowley2 ✉ and Samikshan Dutta 1,3 ✉  \n© The Author(s) 2024  \n\n|  | Resistance to the current Androgen Receptor Signaling Inhibitor (ARSI) therapies has led to higher incidences of therapyinduced neuroendocrine-like prostate cancer (t-NEPC) . This highly aggressive subtype with predominant small-cell-like characteristics is resistant to taxane chemotherapies and has a dismal overall survival. t-NEPCs are mostly treated with platinumbased drugs with a combination of etoposide or taxane and have less selectivity and high systemic toxicity, which often limit their clinical potential. During t-NEPC transformation, adenocarcinomas lose their luminal features and adopt neuro-basal characteristics. Whether the adaptive neuronal characteristics of t-NEPC are responsible for such taxane resistance remains unknown. Pathway analysis from patient gene-expression databases indicates that t-NEPC upregulates various neuronal pathways associated with enhanced cellular networks. To identify transcription factor(s) (TF) that could be important for promoting the gene expression for neuronal characters in t-NEPC, we performed ATAC-Seq, acetylated-histone ChIP-seq, and RNA-seq in our NE-like cell line models and analyzed the promoters of transcriptionally active and signiﬁcantly enriched neuroendocrine-like (NE-like) cancer-speciﬁc genes. Our results indicate that Pax5 could be an important transcription factor for neuronal gene expression and speciﬁc to t-NEPC. Pathway analysis revealed that Pax5 expression is involved in axonal guidance, neurotransmitter regulation, and neuronal adhesion, which are critical for strong cellular communications. Further results suggest that depletion of Pax5 disrupts neurite-mediated cellular communication in NE-like cells and reduces surface growth factor receptor activation, thereby, sensitizing them to docetaxel therapies. Moreover, t-NEPC-speciﬁc hydroxymethylation of Pax5 promoter CpG islands favors Pbx1 binding to induce Pax5 expression. Based on our study, we concluded that continuous exposure to ARSI therapies leads to epigenetic modiﬁcations and Pax5 activation in t-NEPC, which promotes the expression of genes necessary to adopt taxane-resistant NE-like cancer. Thus, targeting the Pax5 axis can be beneﬁcial for reverting their |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| taxane sensitivity. |  |  |\n|  | Cell Death and Disease (2024)15:617; [https://doi.org/10.1038/s41419-024-06916-y](https://doi.org/10.1038/s41419-024-06916-y) |  |\n|  |  |  |\n\nINTRODUCTION  \nHormone sensitive recurrent or metastatic prostate cancer is preferentially treated with androgen deprivation therapies (ADT) alone or in combination with androgen receptor signaling axis inhibitors (ARSIs) such as abiraterone acetate or enzalutamide [1, 2] . However, over the time, most of these patients become resistant to ARSI therapies and progress to castration-resistant prostate cancer (CRPC) [1, 3]. CRPC is highly heterogeneous but still predominantly adenocarcinoma in nature, which are generally, treated with ﬁrst-line taxanebased chemotherapies following ARSI resistance [4–6] . However, ~20% of these ARSI-resistant cases showed  \nneuroendocrine-like  \nneuroendocrine-like  \ntransformation prostate cancer  \n[therapy-induced (t-NEPC) or  \nneuroendocrine-like cancer (NE-like)], and often presented as sm","cbCainCTkCIxOaWY","https://ap.wps.com/l/cbCainCTkCIxOaWY","pdf",6564641,18,"English","# Introduction\n## Background on ARSI resistance and t-NEPC\n## Rationale for identifying molecular regulators\n# Methods and key findings","[{\"question\":\"What problem does the study address in t-NEPC?\",\"answer\":\"The study addresses why therapy-induced neuroendocrine-like prostate cancer becomes resistant to taxane-based therapies despite prior androgen receptor signaling inhibitor treatment.\"},{\"question\":\"How did the researchers identify transcription factors involved in neuroendocrine-like gene programs?\",\"answer\":\"They performed ATAC-seq, acetylated-histone ChIP-seq, and RNA-seq in NE-like cell line models, then analyzed promoters of transcriptionally active and significantly enriched neuroendocrine-like cancer-specific genes.\"},{\"question\":\"What is Pax5’s proposed role in docetaxel resistance and tumor-cell communication?\",\"answer\":\"Pax5 is proposed as an important transcription factor for neuronal gene expression in t-NEPC, and its depletion disrupts neurite-mediated cellular communication while reducing growth factor receptor activation, thereby sensitizing cells to docetaxel.\"}]","Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers | PDF",1790043323,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57c06cb13061c5945e1d8ba9a1b4b1e0.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56217663b6b668686dfbc9256f4e8e2e.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a93f020ba50421116790829af476c8a3.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6ac6b7687516e16dd5f910030bd1284.webp",980,1301]